2024 Q2 Form 10-K Financial Statement
#000149315224014860 Filed on April 16, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
Revenue | $13.00K | $14.00K | $12.00K |
YoY Change | 180.0% | -91.11% | |
Cost Of Revenue | $0.00 | ||
YoY Change | -100.0% | ||
Gross Profit | $12.00K | ||
YoY Change | -88.89% | ||
Gross Profit Margin | 100.0% | ||
Selling, General & Admin | $2.882M | $4.910M | |
YoY Change | -53.85% | -16.82% | |
% of Gross Profit | 40916.67% | ||
Research & Development | $342.0K | $200.0K | $1.176M |
YoY Change | -79.88% | -81.82% | 5.0% |
% of Gross Profit | 9800.0% | ||
Depreciation & Amortization | $49.00K | $78.00K | $91.00K |
YoY Change | -46.74% | -7.14% | 9.64% |
% of Gross Profit | 758.33% | ||
Operating Expenses | $5.305M | $3.451M | $6.179M |
YoY Change | -51.37% | -53.31% | -13.05% |
Operating Profit | -$5.292M | -$3.437M | -$6.167M |
YoY Change | -51.49% | -53.47% | -11.87% |
Interest Expense | -$3.000K | $1.000K | |
YoY Change | -175.0% | -50.0% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$2.000K | $25.00K | $38.00K |
YoY Change | -99.11% | ||
Pretax Income | -$3.911M | -$3.415M | -$6.128M |
YoY Change | -64.86% | -53.74% | -12.41% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$3.915M | -$3.402M | -$6.051M |
YoY Change | -64.71% | -53.6% | -14.11% |
Net Earnings / Revenue | -30115.38% | -24300.0% | -50425.0% |
Basic Earnings Per Share | -$0.30 | -$0.36 | |
Diluted Earnings Per Share | -$0.30 | -$0.36 | -$0.70 |
COMMON SHARES | |||
Basic Shares Outstanding | 11.20M shares | 9.856M shares | 88.11M shares |
Diluted Shares Outstanding | 12.92M shares | 9.856M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $506.0K | $293.0K | |
YoY Change | -66.56% | -36.03% | |
Cash & Equivalents | $2.104M | $416.0K | $200.0K |
Short-Term Investments | $90.00K | $103.0K | |
Other Short-Term Assets | $211.0K | ||
YoY Change | -35.08% | ||
Inventory | $0.00 | ||
Prepaid Expenses | $163.0K | $220.0K | $206.0K |
Receivables | $54.00K | $14.00K | $24.00K |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $2.386M | $740.0K | $528.0K |
YoY Change | 20.08% | -65.58% | -53.19% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $137.0K | $182.0K | $921.0K |
YoY Change | -77.94% | -71.11% | 38.5% |
Goodwill | |||
YoY Change | |||
Intangibles | $1.000K | $1.000K | |
YoY Change | 0.0% | 0.0% | |
Long-Term Investments | $4.000K | $17.00K | |
YoY Change | -95.74% | -85.83% | |
Other Assets | $43.00K | $43.00K | |
YoY Change | -82.38% | -2.27% | |
Total Long-Term Assets | $721.0K | $849.0K | $1.270M |
YoY Change | -65.05% | -72.14% | -57.41% |
TOTAL ASSETS | |||
Total Short-Term Assets | $2.386M | $740.0K | $528.0K |
Total Long-Term Assets | $721.0K | $849.0K | $1.270M |
Total Assets | $3.107M | $1.589M | $1.798M |
YoY Change | -23.28% | -69.42% | -56.25% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $5.129M | $4.465M | |
YoY Change | 89.05% | 41.07% | |
Deferred Revenue | $16.00K | ||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.976M | $5.232M | $4.582M |
YoY Change | -10.68% | 85.93% | 40.51% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $500.0K | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | $60.00K | $103.0K | |
YoY Change | -83.7% | -77.21% | |
Total Long-Term Liabilities | $15.00K | $560.0K | $103.0K |
YoY Change | -94.68% | 52.17% | -77.21% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.976M | $5.232M | $4.582M |
Total Long-Term Liabilities | $15.00K | $560.0K | $103.0K |
Total Liabilities | $2.991M | $5.792M | $4.711M |
YoY Change | -17.24% | 82.02% | 26.88% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$252.3M | -$248.4M | -$245.0M |
YoY Change | 7.65% | 11.25% | 13.45% |
Common Stock | $15.00K | $11.00K | $9.000K |
YoY Change | -79.45% | -83.58% | -83.64% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$6.000K | -$4.321M | -$2.913M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $3.107M | $1.589M | $1.798M |
YoY Change | -23.28% | -69.42% | -56.25% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$3.915M | -$3.402M | -$6.051M |
YoY Change | -64.71% | -53.6% | -14.11% |
Depreciation, Depletion And Amortization | $49.00K | $78.00K | $91.00K |
YoY Change | -46.74% | -7.14% | 9.64% |
Cash From Operating Activities | -$1.300M | -$2.943M | |
YoY Change | -76.79% | -28.46% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $6.000K | ||
YoY Change | -89.66% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$6.000K | ||
YoY Change | -89.66% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $5.000M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $1.540M | 2.742M | |
YoY Change | -77.18% | -24.71% | |
NET CHANGE | |||
Cash From Operating Activities | -$1.300M | -2.943M | |
Cash From Investing Activities | -6.000K | ||
Cash From Financing Activities | $1.540M | 2.742M | |
Net Change In Cash | $240.0K | -207.0K | |
YoY Change | -78.24% | -60.94% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.300M | -$2.943M | |
Capital Expenditures | $6.000K | ||
Free Cash Flow | -$1.300M | -$2.949M | |
YoY Change | -76.97% | -29.31% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001530766 | |
CY2022Q4 | BSGM |
Employee Advance
EmployeeAdvance
|
usd | |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
usd | |
CY2023Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
usd | |
CY2023Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
usd | |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
usd | |
CY2022 | BSGM |
Adjustments To Additional Paid In Capital Issuance Of Subsidiary Stock In Settlement Of Debt To Parent
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSubsidiaryStockInSettlementOfDebtToParent
|
usd | |
CY2023 | BSGM |
Stock Issued During Period Value Common Stock Issued For Exercise Of Warrants Cashlessly
StockIssuedDuringPeriodValueCommonStockIssuedForExerciseOfWarrantsCashlessly
|
usd | |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
usd | |
CY2023 | us-gaap |
Equity Fair Value Adjustment
EquityFairValueAdjustment
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
usd | |
CY2022 | BSGM |
Increase Decrease Customer Deposits
IncreaseDecreaseCustomerDeposits
|
usd | |
CY2023 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
usd | |
CY2023 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
usd | |
CY2023Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
usd | |
CY2023Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
usd | |
CY2023Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
usd | |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
usd | |
CY2023Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
usd | |
CY2023Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
usd | |
CY2023 | us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
usd | |
CY2021Q4 | us-gaap |
Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
|
usd | |
CY2023Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
usd | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2022 | BSGM |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsIntrinsicValue
|
usd | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2023 | BSGM |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsIntrinsicValue
|
usd | |
CY2023 | BSGM |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Expired Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedExpiredIntrinsicValue
|
usd | |
CY2022Q1 | BSGM |
Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
|
usd | |
CY2023Q4 | BSGM |
Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-38659 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
BIOSIG TECHNOLOGIES, INC. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
26-4333375 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
55 Greens Farms Road 1st Floor | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
76956461 | usd |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
11198174 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Marlton, New Jersey | |
CY2023Q4 | us-gaap |
Cash
Cash
|
190000 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
357000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
24000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
9000 | usd |
CY2023Q4 | BSGM |
Employee Advance
EmployeeAdvance
|
5000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
336000 | usd |
CY2023Q4 | us-gaap |
Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
|
103000 | usd |
CY2022Q4 | us-gaap |
Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
|
101000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
206000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
325000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
528000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1128000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
509000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
665000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
412000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
705000 | usd |
CY2022Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
1141000 | usd |
CY2023Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
|
17000 | usd |
CY2022Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
|
120000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
288000 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
307000 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
44000 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
44000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
1798000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
4110000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4116000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2852000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
16000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
5000 | usd |
CY2023Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
101000 | usd |
CY2022Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
91000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
349000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
313000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4582000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3261000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
103000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
452000 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
103000 | usd |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
452000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
4685000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
3713000 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
105000 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
105000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9040043 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9040043 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5505068 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5505068 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
9000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
5000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
241988000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
216282000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-245015000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-215974000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3018000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
313000 | usd |
CY2023Q4 | us-gaap |
Minority Interest
MinorityInterest
|
26000 | usd |
CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
-21000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2992000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
292000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1798000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4110000 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
18000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
286000 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
57000 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
18000 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
229000 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5092000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5821000 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
23077000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21380000 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
361000 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
293000 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
28530000 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
27494000 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-28512000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27265000 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-187000 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-28690000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-27262000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28690000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-27262000 | usd |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
351000 | usd |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-210000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29041000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27052000 | usd |
CY2023 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
9000 | usd |
CY2022 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
9000 | usd |
CY2022 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
210000 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-29050000 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-27271000 | usd |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.95 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.95 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-6.33 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-6.33 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7351794 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7351794 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4307244 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4307244 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
12460000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
2109000 | usd |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
528000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
8283000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2070000 | usd |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.50 | |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
218000 | usd |
CY2022 | BSGM |
Stock Issued During Period Value Issued In Settlement Of Debt
StockIssuedDuringPeriodValueIssuedInSettlementOfDebt
|
105000 | usd |
CY2022 | BSGM |
Adjustments To Additional Paid In Capital Change In Fair Value Of Modified Options
AdjustmentsToAdditionalPaidInCapitalChangeInFairValueOfModifiedOptions
|
15000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2303000 | usd |
CY2022 | us-gaap |
Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
|
210000 | usd |
CY2022 | BSGM |
Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
|
210000 | usd |
CY2022 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
9000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-27262000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
292000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
292000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
7617000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
7617000 | usd |
CY2023 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1067000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
15301000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
60000 | usd |
CY2023 | BSGM |
Stock Issued During Period Value Issued In Settlement Of Debt
StockIssuedDuringPeriodValueIssuedInSettlementOfDebt
|
105000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
1971000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
361000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
218000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
60000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
15301000 | usd |
CY2023 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
9000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28690000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2992000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2992000 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28690000 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-27262000 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
361000 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
293000 | usd |
CY2023 | BSGM |
Non Cash Lease Expense
NonCashLeaseExpense
|
293000 | usd |
CY2022 | BSGM |
Non Cash Lease Expense
NonCashLeaseExpense
|
373000 | usd |
CY2023 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1976000 | usd |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7978000 | usd |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4412000 | usd |
CY2022 | us-gaap |
Equity Fair Value Adjustment
EquityFairValueAdjustment
|
-15000 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
15000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9000 | usd |
CY2023 | us-gaap |
Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
|
-101000 | usd |
CY2022 | us-gaap |
Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
|
220000 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
5000 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
498000 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-284000 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-118000 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-30000 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-5000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-32000 | usd |
CY2023 | BSGM |
Increase Decrease Customer Deposits
IncreaseDecreaseCustomerDeposits
|
16000 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1370000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
776000 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-313000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-365000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17313000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-21705000 | usd |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
186000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
168000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-186000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-168000 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
15301000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
8283000 | usd |
CY2023 | BSGM |
Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs
ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts
|
60000 | usd |
CY2022 | BSGM |
Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs
ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts
|
2070000 | usd |
CY2023 | us-gaap |
Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
|
1971000 | usd |
CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
218000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
17332000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10571000 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-167000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-11302000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
357000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11659000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
190000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
357000 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1000 | usd |
CY2023 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
105000 | usd |
CY2022 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
105000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
9000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
9000 | usd |
CY2022 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
210000 | usd |
CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
502000 | usd |
CY2019 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
894869 | shares |
CY2020 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
894869 | shares |
CY2024Q1 | BSGM |
Priceper Share
PriceperShare
|
1.00 | |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
5000000 | usd |
CY2024Q2 | us-gaap |
Auction Market Preferred Securities Stock Series Liquidation Value
AuctionMarketPreferredSecuritiesStockSeriesLiquidationValue
|
35000000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
200000 | usd |
CY2023Q4 | BSGM |
Working Capital Deficit
WorkingCapitalDeficit
|
4100000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17300000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
5000 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zhZcptOovJR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
4333 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P30M | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P1Y | |
CY2022 | BSGM |
Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
|
0.02 | pure |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
37000 | usd |
CY2022 | us-gaap |
Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
|
254000 | usd |
CY2022 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-286000 | usd |
CY2022Q4 | us-gaap |
Policyholder Funds
PolicyholderFunds
|
5000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
5000 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zOeBfdZocI3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zaPlZKz2IHLl">Concentrations of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit. At December 31, 2023 and 2022, deposits in excess of FDIC limits were <span id="xdx_90F_eus-gaap--CashUninsuredAmount_iI_dxL_c20231231_znZF30mMIRul" title="Cash, uninsured amount::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0817">nil</span></span> and $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pn4n6_c20221231_zYDmVZUeNi29" title="Cash, uninsured amount">0.05</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
50000.00 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1976000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1477000 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
1976000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
1477000 | usd |
CY2022Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
336000 | usd |
CY2022Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
1141000 | usd |
CY2023Q4 | BSGM |
Allowance For Inventory
AllowanceForInventory
|
1976 | usd |
CY2023Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
43000 | usd |
CY2022Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
43000 | usd |
CY2023Q4 | us-gaap |
Indefinite Lived Trademarks
IndefiniteLivedTrademarks
|
1000 | usd |
CY2022Q4 | us-gaap |
Indefinite Lived Trademarks
IndefiniteLivedTrademarks
|
1000 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
44000 | usd |
CY2022Q4 | us-gaap |
Other Assets
OtherAssets
|
44000 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5100000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5800000 | usd |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3580561 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
966779 | shares |
CY2023 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
19106 | usd |
CY2022 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
19006 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1452000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1266000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
943000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
601000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
509000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
665000 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
342028 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
273915 | usd |
CY2023 | BSGM |
Number Of Leases
NumberOfLeases
|
2 | integer |
CY2023Q4 | BSGM |
Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
|
995000 | usd |
CY2022Q4 | BSGM |
Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
|
995000 | usd |
CY2023Q4 | BSGM |
Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
|
583000 | usd |
CY2022Q4 | BSGM |
Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
|
290000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
412000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
705000 | usd |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
378263 | usd |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
438129 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
452000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
765000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
349000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
313000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
103000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
452000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
370000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
106000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
476000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
24000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
452000 | usd |
CY2023 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
337000 | usd |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
373000 | usd |
CY2023 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
33000 | usd |
CY2022 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
37000 | usd |
CY2023 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
8000 | usd |
CY2022 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
28000 | usd |
CY2023 | us-gaap |
Lease Cost
LeaseCost
|
378000 | usd |
CY2022 | us-gaap |
Lease Cost
LeaseCost
|
438000 | usd |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
4333 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P30M | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P1Y | |
CY2022 | BSGM |
Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
|
0.02 | pure |
CY2022Q4 | us-gaap |
Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
|
4000 | usd |
CY2022Q4 | us-gaap |
Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
|
221000 | usd |
CY2023 | BSGM |
Sales Type Lease Invoiced To Customer
SalesTypeLeaseInvoicedToCustomer
|
-100000 | usd |
CY2023 | us-gaap |
Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
|
3000 | usd |
CY2023Q4 | us-gaap |
Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
|
4000 | usd |
CY2023Q4 | us-gaap |
Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
|
120000 | usd |
CY2022 | us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
254000 | usd |
CY2022 | BSGM |
Sales Type Lease Invoiced To Customer
SalesTypeLeaseInvoicedToCustomer
|
-39000 | usd |
CY2022 | us-gaap |
Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
|
2000 | usd |
CY2022Q4 | us-gaap |
Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
|
4000 | usd |
CY2022Q4 | us-gaap |
Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
|
221000 | usd |
CY2023Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
|
104000 | usd |
CY2023Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
|
13000 | usd |
CY2023Q4 | us-gaap |
Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
|
4000 | usd |
CY2023Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
|
121000 | usd |
CY2023Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
|
1000 | usd |
CY2023Q4 | us-gaap |
Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
|
120000 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1277000 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
646000 | usd |
CY2023Q4 | BSGM |
Accrued Reimbursements Current
AccruedReimbursementsCurrent
|
9000 | usd |
CY2022Q4 | BSGM |
Accrued Reimbursements Current
AccruedReimbursementsCurrent
|
33000 | usd |
CY2023Q4 | BSGM |
Accrued Consulting Current
AccruedConsultingCurrent
|
804000 | usd |
CY2022Q4 | BSGM |
Accrued Consulting Current
AccruedConsultingCurrent
|
546000 | usd |
CY2023Q4 | BSGM |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
802000 | usd |
CY2022Q4 | BSGM |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
625000 | usd |
CY2023Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
333000 | usd |
CY2022Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
256000 | usd |
CY2023Q4 | BSGM |
Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
|
290000 | usd |
CY2022Q4 | BSGM |
Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
|
220000 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
601000 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
513000 | usd |
CY2022Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
13000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4116000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2852000 | usd |
CY2022 | BSGM |
Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
|
209682 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9040043 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9040043 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5505068 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5505068 | shares |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
14.00 | |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.50 | |
CY2022Q4 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
87300 | shares |
CY2022Q4 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
218250 | usd |
CY2022 | BSGM |
Stock Issued During Period Value Issued For Services Fair Value
StockIssuedDuringPeriodValueIssuedForServicesFairValue
|
1060740 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
230000 | usd |
CY2023Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
77405 | shares |
CY2023Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
7.85 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P6M | ||
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
2200000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
|
the exercise price of an Incentive Stock Option should not be less than 110% of fair value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair value for a grantee who is not 10% stockholder | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P10Y | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
|
the exercise price of an Incentive Stock Option should not be less than 110% of fair value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair value for a grantee who is not 10% stockholder | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P10Y | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
603229 | shares |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y8M12D | |
CY2023Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
386507 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
456852 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
45.70 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y10M24D | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
142800 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
11.20 | |
CY2022 | BSGM |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
|
P10Y | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
144100 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
455552 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
45.70 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y10M24D | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
195710 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
10.00 | |
CY2023 | BSGM |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
|
P10Y | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
48033 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
603229 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
25.67 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y8M12D | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
37671000 | usd |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
386507 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
33.53 | |
CY2023 | BSGM |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
|
P5Y10M24D | |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
35425000 | usd |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
|
4.75 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
142800 | shares |
CY2022 | BSGM |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
|
P10Y | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
195710 | shares |
CY2023 | BSGM |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
|
P10Y | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
7.72 | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
8.00 | |
CY2022Q1 | BSGM |
Options Modified
OptionsModified
|
10000 | shares |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
15181 | usd |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.8386 | pure |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1445915 | usd |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1829233 | usd |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
997894 | usd |
CY2023 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P0Y6M7D | |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2748371 | shares |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
32727 | shares |
CY2022Q4 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
90865 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.9626 | pure |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0382 | pure |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
126385 | shares |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
5.31 | |
CY2022 | BSGM |
Class Of Warrants Or Right Issued
ClassOfWarrantsOrRightIssued
|
427120 | shares |
CY2022 | BSGM |
Warrants Weighted Average Remaining Contractual Term Issued
WarrantsWeightedAverageRemainingContractualTermIssued
|
P4Y | |
CY2022 | BSGM |
Class Of Warrants Or Right Expried
ClassOfWarrantsOrRightExpried
|
-87300 | shares |
CY2022Q4 | BSGM |
Class Of Warrant Or Rights Outstanding Intrinsic Value
ClassOfWarrantOrRightsOutstandingIntrinsicValue
|
3960 | usd |
CY2023 | BSGM |
Class Of Warrants Or Right Issued
ClassOfWarrantsOrRightIssued
|
2332752 | shares |
CY2023 | BSGM |
Warrants Weighted Average Remaining Contractual Term Issued
WarrantsWeightedAverageRemainingContractualTermIssued
|
P3Y9M18D | |
CY2023 | BSGM |
Class Of Warrants Or Right Exercised
ClassOfWarrantsOrRightExercised
|
-6098 | shares |
CY2023Q4 | BSGM |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
|
7.40 | |
CY2023 | BSGM |
Warrants Outstanding Weighted Average Remaining Contractual Term
WarrantsOutstandingWeightedAverageRemainingContractualTerm
|
P3Y8M12D | |
CY2023 | BSGM |
Warrants Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
WarrantsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
|
P3Y8M12D | |
CY2023Q4 | BSGM |
Class Of Warrant Or Rights Vested And Expected To Vest Outstanding Intrinsic Value
ClassOfWarrantOrRightsVestedAndExpectedToVestOutstandingIntrinsicValue
|
1717104 | usd |
CY2023 | BSGM |
Warrants Exercisable Weighted Average Remaining Contractual Term
WarrantsExercisableWeightedAverageRemainingContractualTerm
|
P3Y7M6D | |
CY2023Q4 | BSGM |
Class Of Warrant Or Rights Exercisable Intrinsic Value
ClassOfWarrantOrRightsExercisableIntrinsicValue
|
1711424 | usd |
CY2023Q4 | us-gaap |
Share Price
SharePrice
|
4.75 | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
90865 | usd |
CY2023 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
|
0 | usd |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
37750 | shares |
CY2023Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
26000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
|
vesting quarterly over one year | |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
301600 | usd |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
|
vesting quarterly over one year, and 25,000 vesting on the one-year anniversary | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
190920 | usd |
CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
|
the exercise price of an Incentive Stock Option should not be less than 110% of fair market value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair market value for a grantee who is not 10% stockholder | |
CY2019Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
2650071 | shares |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P0Y6M | |
CY2023 | BSGM |
Warrants Granted Weighted Average Remaining Contractual Term
WarrantsGrantedWeightedAverageRemainingContractualTerm
|
P5Y | |
CY2023 | BSGM |
Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
|
753000 | usd |
CY2023 | BSGM |
Average Noncontrolling Interest Percentage Of Profitlosses
AverageNoncontrollingInterestPercentageOfProfitlosses
|
0.47 | pure |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
351000 | usd |
CY2022 | BSGM |
Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
|
-674000 | usd |
CY2022 | BSGM |
Net Income Loss Of Non Controlling Interest
NetIncomeLossOfNonControllingInterest
|
-674000 | usd |
CY2022 | BSGM |
Average Noncontrolling Interest Percentage Of Profitlosses
AverageNoncontrollingInterestPercentageOfProfitlosses
|
0.31 | pure |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-210000 | usd |
CY2021Q4 | us-gaap |
Minority Interest
MinorityInterest
|
219000 | usd |
CY2022 | BSGM |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Noncontrolling Interest For Settlement Of Shares Issued To Settle Debt To Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNoncontrollingInterestForSettlementOfSharesIssuedToSettleDebtToParent
|
292000 | usd |
CY2022 | us-gaap |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
|
322000 | usd |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-210000 | usd |
CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
-21000 | usd |
CY2023 | us-gaap |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
|
296000 | usd |
CY2023 | us-gaap |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
|
600000 | usd |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
351000 | usd |
CY2023Q4 | us-gaap |
Minority Interest
MinorityInterest
|
26000 | usd |
CY2023 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
229744 | usd |
CY2022 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
247622 | usd |
CY2023 | us-gaap |
Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
|
1563203 | usd |
CY2023Q4 | us-gaap |
Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
|
775782 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
18000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
286000 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
28530000 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
27494000 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-28512000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27265000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
1798000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
4110000 | usd |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
160926000 | usd |
CY2023 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
7739000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
47679000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
55418000 | usd |
CY2023 | BSGM |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
|
0.269 | pure |
CY2023 | BSGM |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
|
0.269 | pure |
CY2022 | BSGM |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
|
0.269 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
0 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
0.336 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.269 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.605 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0000 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0000 | pure |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
43329000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
36977000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
9680000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
9291000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
2409000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
1411000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
55418000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
47679000 | usd |